x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

188 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

ESPANHA

Navarra
PAMPLONA

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors (Completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

REINO UNIDO

Avon
BRISTOL

A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma - UK
Bristol Royal Infirmary
University Hospitals Bristol NHS Foundation Trust HQ

REINO UNIDO

Oxfordshire
OXFORD

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma - UK
Freeman Hospital, The newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust

ALEMANHA

Baden-Württemberg
TÜBINGEN

ALEMANHA

Baden-Württemberg
TÜBINGEN

Ensaio a decorrerCheckMate 459: A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma - DE
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin I - Gastroenterologie, Hepatologie und Infektiologie

ALEMANHA

Bayern
MÜNCHEN

ALEMANHA

Bayern
MÜNCHEN

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

ESPANHA

Cataluña
BARCELONA

ESPANHA

Cataluña
BARCELONA

Ensaio a decorrerRESORCE: A randomized, double blind, placebo-controlled, multicenter phase III study of Regorafenib in patients with Hepatocellular Carcinoma after Sorafenib - ES
Universitat de Barcelona. Facultat de Medicina
Oncología Hepática - Barcelona Clinic Liver Cancer (BCLC)

ESPANHA

Cataluña
BARCELONA

Ensaio em fase de recrutamentoEnsaio a decorrerHEPANOVA: A Phase II Trial of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) - ES
Vall d'Hebron Instituto de Oncología - Centro Cellex
Grupo de Tumores Gastrointestinales y Endocrinos

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
LYON

Ensaio em fase de recrutamentoEnsaio a decorrerSOMAPROTECT01 : Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma by Laparotomy: Multicenter Randomized Double-blind Placebo Controlled Trial (Phase III)
CHU de Lyon HCL - GH Nord-Hôpital de la Croix Rousse
Service de chirurgie générale, digestive et transplantations hépatiques et intestinales

FRANCA

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Protocole SIOPEL 3 - Treatment protocole of hepatoblastomas and hepatocarcinomas (Phase III) - Terminated -
CHRU de Besançon - Hôpital Jean Minjoz
Consultation spécialisée d'Hémato-oncologie pédiatrique

FRANCA

BOURGOGNE-FRANCHE-COMTE
DIJON

FRANCA

BOURGOGNE-FRANCHE-COMTE
DIJON

FRANCA

GRAND-EST
REIMS

Ensaio a decorrerA Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC) - FR
CHU de Reims - Hôpital Robert Debré
Service d'Hépato-Gastroentérologie et de Cancérologie digestive

FRANCA

HAUTS-DE-FRANCE
LILLE

An Open-label, Randomized Phase 3 Study of the Efficacy and Tolerability of Linifanib (ABT-869) versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma (HCC)
CHRU de Lille - Hôpital Claude Huriez
Service des Maladies de l'appareil digestif et nutrition - Hépatologie

FRANCA

HAUTS-DE-FRANCE
LILLE

FRANCA

HAUTS-DE-FRANCE
LILLE

FRANCA

ILE-DE-FRANCE
CRÉTEIL

Advanced hepatocellular carcinoma on Child B cirrhosis: Tolerance and efficacy of Torisel® (temsirolimus).
CHU Henri Mondor
Service d'Hépato-Gastro-Entérologie - Hépatologie

REINO UNIDO

Greater London
LONDON

SIOPEL 3: Liver Tumour Studies - Chemotherapy of children with hepatoblastoma and hepatocellular carcinoma (Phase III) - UK
University College London Hospitals, NHS Foundation Trust
The Somers Clinical Research Facility Level 1

REINO UNIDO

Greater Manchester
ADDRESS: NOT PROVIDED - UK

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ensaio a decorrerSTEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Ensaio (s) clínico (s) multinacional (ais)